Euro-BioImaging is the European landmark research infrastructure for biological and biomedical imaging as recognised by the European Strategy Forum on Research Infrastructures (ESFRI). Through Euro-BioImaging, life scientists can access imaging instruments, expertise, training opportunities and data management services that they might not find at their home institutions or among their collaboration partners. All scientists, regardless of their affiliation, area of expertise or field of activity can benefit from these pan-European open access services, which are provided with high quality standards by leading imaging facilities.
The fully distributed infrastructure of Euro-BioImaging is coordinated by a Hub and offers its services via 21 internationally renowned imaging facilities called Nodes, which are located across 8 countries and the European Molecular Biology Laboratory, EMBL. The Euro-BioImaging Hub consists of Finland (Turku) as the headquarters, EMBL as the community-specific section for biological imaging and Italy (Torino) as the community-specific section for biomedical imaging. By facilitating user access to high quality imaging facilities, resources and services, Euro-BioImaging will boost the productivity and impact of research across Europe.
Euro-BioImaging was granted the legal status of an ERIC (European Research Infrastructure Consortium) on 29 Oct 2019, and Euro-BioImaging became fully operational in December 2019. Before that, since May 2016, Euro-BioImaging conducted limited interim operation. Euro-BioImaging services are accessed through this Web Portal, with some services requiring logging in.
Euro-BioImaging members. Full members are shown in green, observers in light green, and partners to join soon in light blue. Additional partners are in progress. The three Hub hosts Finland, EMBL and Italy our outlined in dark green.
Euro-BioImaging is managed by its Hub and governed by the Euro-BioImaging Board. More information on Euro-BioImaging governance and organization will be added to this page later.